The Drug Enforcement Administration (DEA) has issued a statement further clarifying their interpretation and enforcement of the Controlled Substances Act (CSA). In their statement, they make clear the critical difference between CBD and THC, a distinction that cannabidiol retailers have been fighting to bring to light.
The DEA agrees that the CSA targets marijuana specifically because of the psychoactive properties found in THC, its primary active ingredient. Because THC is an intoxicating agent, and CBD is not, the DEA now sees fit to clarify that "Products and materials that are made from the cannabis plant and which fall outside the CSA definition of marijuana… are not controlled under the CSA. Such products may accordingly be sold and otherwise distributed throughout the United States without restriction under the CSA."
This is incredible news and confirmation for the millions of CBD users nationwide who have now gained yet another layer of legitimacy to their usage of cannabidiol. The statement by the DEA now means that:
© 2017 by Revival cbd
cbd products are intended for people of legal age and are not to be used by anyone under the age of 21. Our products are not intended to diagnose, treat, cure or prevent any addiction or disease. Please keep out of reach of children and/or pets. Please do not use if you are pregnant, or are thinking of becoming pregnant. By purchasing our products, you agree to use at your own risk. Under no circumstances will revival cbd be held responsible or liable, directly or indirectly, for any loss or damage that is caused or alleged to have been caused in connection with use of, or reliance on any product on this site. If you experience any possible side effects, stop using the product and immediately consult a physician.
Revival CBD contains NO THC.